{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:06:55Z","timestamp":1790780815589,"version":"4.1.0"},"reference-count":43,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Neuropsychopharm Rep"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mild depression lacks a consistent definition across diagnostic criteria and rating scales, posing challenges to standardizing treatment strategies. International guidelines predominantly recommend psychotherapy as the first\u2010line treatment for mild depression, while the use of antidepressants remains contentious. Supplements such as omega\u20103 fatty acids, St. John's Wort, and magnesium have garnered attention as alternative therapeutic options for depression. This systematic review aims to assess the efficacy of pharmacological interventions, including supplements, in the treatment of mild depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Comprehensive searches were performed in PubMed and Embase through November 2024 to identify randomized controlled trials (RCTs) investigating pharmacotherapy or supplements for mild depression diagnosed using standardized criteria. Eligible studies underwent screening and risk of bias assessment utilizing the ROB2 tool. Data on remission rates, symptom improvement, dropout rates, and adverse events were extracted, with meta\u2010analyses conducted where applicable.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Eight RCTs comprising 1049 participants met inclusion criteria. Among the agents studied, St. John's Wort was analyzed in two trials, both comparing it to fluoxetine. A meta\u2010analysis found no significant difference in response rates between the two treatments (risk ratio [RR]\u2009=\u20090.96, 95% CI: 0.78\u20131.18) or dropout rates (RR\u2009=\u20091.08, 95% CI: 0.62\u20131.88). For other agents, single studies evaluated their effects. Eicosapentaenoic acid and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Rhodiola rosea<\/jats:italic>\n                      <\/jats:styled-content>\n                      demonstrated significant improvements in depressive symptoms compared to placebo. In non\u2010blinded trials, magnesium chloride showed efficacy in alleviating depressive symptoms. Other interventions, such as lavender, lemon balm, and transcranial electroacupuncture stimulation, were as effective as antidepressants. Conversely, S\u2010adenosylmethionine did not produce significant improvements relative to placebo.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This review demonstrates that certain supplements, such as eicosapentaenoic acids and\n                      <jats:styled-content style=\"fixed-case\">\n                        <jats:italic>Rhodiola rosea<\/jats:italic>\n                      <\/jats:styled-content>\n                      , are therapeutic options for mild depression. However, no RCTs compared antidepressants directly to placebo for mild depression. The paucity of high\u2010quality RCTs exclusively targeting mild depression limits definitive conclusions, warranting further rigorous research.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/npr2.70008","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:38:04Z","timestamp":1741696684000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of Pharmacological Interventions in Milder Depression: A Systematic Review and Meta\u2010Analysis"],"prefix":"10.1002","volume":"45","author":[{"given":"Minoru","family":"Urata","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5399-7946","authenticated-orcid":false,"given":"Hitoshi","family":"Sakurai","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Ueno","sequence":"additional","affiliation":[{"name":"Brain Health Imaging Centre Centre for Addiction and Mental Health  Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Maruki","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Tada","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Uchida","sequence":"additional","affiliation":[{"name":"Uchida Clinic  Tokyo Japan"},{"name":"Department of Neuropsychiatry Keio University School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Murao","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Tomita","sequence":"additional","affiliation":[{"name":"Oizumi Hospital  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9678-8776","authenticated-orcid":false,"given":"Hajime","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Psychiatry &amp; Behavioral Science Juntendo University Graduate School of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6727-7272","authenticated-orcid":false,"given":"Masaki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kansai Medical University  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Tsuboi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry Kyorin University Faculty of Medicine  Tokyo Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,2,27]]},"reference":[{"key":"e_1_2_11_2_1","unstructured":"World Health Organization \u201cInternational Classification of Diseases 11th Revision \u201daccessed September 29 2024 https:\/\/icd.who.int\/en."},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association \u201cDiagnostic & Statistical Manual of Mental Disorders Fifth Edition Text Revision \u201d(2022).","DOI":"10.1176\/appi.books.9780890425787"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.23.1.56"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471\u2010244X\u201012\u2010181"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1177\/07067437241245384"},{"key":"e_1_2_11_7_1","unstructured":"National Institute for Health and Care Excellence (NICE) \u201cDepression in Adults: Treatment and Management \u201d(2022) accessed October 23 2024 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK583074\/."},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/acps.12886"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41386\u2010019\u20100523\u20104"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2215\u20100366(19)30216\u20100"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj\u20102021\u2010067606"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.04.078"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000100"},{"key":"e_1_2_11_14_1","unstructured":"American Psychiatric Association \u201cPractice Guideline for the Treatment of Patients With Major Depressive Disorder Third Edition \u201d(2010)."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.148.5.599"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525\u20101497.2001.016009606.x"},{"key":"e_1_2_11_17_1","volume-title":"Beck Depression Inventory\u2013II","author":"Beck A. T.","year":"1996"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0022\u20103956(82)90033\u20104"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.150.6.782"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1965.01720310065008"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1411"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2012.08.003"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2020.01.065"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0180067"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906\u2010020\u201003003\u20105"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.13512"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00213\u2010019\u201005358\u20101"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1055\/s\u20100031\u20101300417"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1590\/s1516\u201044462006000100007"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2010.03.018"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.08.026"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.23257"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114523002052"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12888\u2010020\u201002656\u20103"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2009.10719785"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2004.08.010"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2016.10.014"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2024.110985"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2016.12.048"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/08039480701643290"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0278\u20105846(02)00342\u20101"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12906\u2010023\u201003978\u2010x"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.11m07078"},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2011.100"}],"container-title":["Neuropsychopharmacology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.70008","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/npr2.70008","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/npr2.70008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T07:07:15Z","timestamp":1783840035000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/npr2.70008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,27]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["10.1002\/npr2.70008"],"URL":"https:\/\/doi.org\/10.1002\/npr2.70008","archive":["Portico"],"relation":{},"ISSN":["2574-173X","2574-173X"],"issn-type":[{"value":"2574-173X","type":"print"},{"value":"2574-173X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,27]]},"assertion":[{"value":"2024-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70008"}}